Royal London Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-127,513
Closed -$22.4M 664
2020
Q1
$22.4M Sell
127,513
-286
-0.2% -$53.9K 0.18% 127
2019
Q4
$24.4M Buy
127,799
+491
+0.4% +$88.6K 0.17% 137
2019
Q3
$21.4M Buy
+127,308
New +$20.7M 0.16% 138
2019
Q2
Sell
-134,997
Closed -$19.8M 658
2019
Q1
$19.8M Sell
134,997
-38,063
-22% -$5.52M 0.16% 141
2018
Q4
$23M Buy
+173,060
New +$28.4M 0.2% 114
2018
Q3
Sell
-174,231
Closed -$29.1M 577
2018
Q2
$29.1M Buy
+174,231
New +$28M 0.29% 78
2013
Q3
Sell
-28,270
Closed -$3.56M 574
2013
Q2
$3.56M Buy
+28,270
New +$3.2M 0.1% 224

Other funds holding AGN

Royal London Asset Management's AGN Position: Q2 2020 in Review

Royal London Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 127,513 shares — an estimated $22.4M sold.

Royal London Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $29.1M in Q2 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Royal London Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Royal London Asset Management sold 127,513 Allergan plc shares in Q2 2020, an estimated $22.4M.
  • Royal London Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 7 quarters.
  • Royal London Asset Management's Allergan plc position peaked at $29.1M in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Royal London Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.